Formulation and evaluation of controlled release antibiotic biodegradable implants for post operative site delivery
Biodegradable implants of ciprofloxacin hydrochloride for post operative site delivery were prepared using glyceryl monostearate and different concentrations of polyethylene glycol (PEG 6000), glycerol and Tween 80 as erosion enhancers by compression and molding technique. Formulations were subjected to in vitro drug release by the USP dissolution method, while promising formulations were subjected to in vitro drug release by the agar gel method and also to stability studies. It was observed that glyceryl monostearate formed hydrophobic matrix and delayed the drug delivery. Antibiotic release profile was controlled by using different combinations of erosion enhancers. The formulation prepared by the compression method showed more delayed release compared to formulations prepared by the molding method.
C. Schmidt, R. Wenz, B. Nies and F. Moll, Antibiotic in vivo/in vitro release, histocompatibility and biodegradation of gentamycin implants on lactic acid polymers and copolymers, J. Control. Rel.37 (1995) 83-94; DOI: 10.1016/0168-3659(95)00067-1.
M.E.A. Mamun, H.A. Khan, I. Dewan and R.U. Jalil, In vitro study on tamsulosin release kinetics from biodegradable PLGA in situ implants, Pak. J. Pharm. Sci.22 (2009) 360-367.
M. Ramchandani and D. Robinson, In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants, J. Control. Rel.54 (1998) 167-175; DOI: 10.1016/s0168-3659(97)00113-2.
P.Y. Wang, C.X. Song, H.F. Sun, H.L. Shi and R.W. Shi, A biodegradable long-term contraceptive implant, Eng. Med. Biol. Soc.6 (1998) 2901-2904; DOI: 10.1109/IEMS.1998.746093.
C. Guse, S. Koennings, F. Kreye, F. Siepmann, A. Goepferich and J. Siepmann, Drug release from lipid-based implants: Elucidation of the underlying mass transport mechanisms, Int. J. Pharm.314 (2006) 137-144; DOI: 10.1016/j.i.jpharm.2005.08.030.
J.C. Shah and S. Allababidi, Glyceryl Monostearate Based Biodegradable Implants for Site Specific Delivery of Drugs, U.S. Pat. 5,891,456, 6 Apr 1999; ref. Chem. Abstr.130 (1999) 271997f.
United States Pharmacopoeia 30, National Formulary 25, United State Pharmacopeial Convection, Rockville 2007, pp. 1759-1760.
S. Allababidi and J. Shah, Kinetic and mechanism of release from glyceryl monostearate based implants: Evaluation of release in a gel simulating in vivo implantations, J. Pharm. Sci.87 (1998) 169-172; DOI: 10.1021/js9703986.
ICH Harmonised Tripartite Guideline, Stability Testing of New Drug Substances and Products, Q1A (R2), Current Step 4 version, 6 February 2003.
P. Costa and J.M.S. Lobo, Modeling and comparison of dissolution profiles, Eur. J. Pharm. Sci.13 (2001) 123-133.